Orlistat as a clomiphene citrate adjuvant in overweight and obese patients with polycystic ovary syndrome.
Phase 4
- Conditions
- recruiting
- Registration Number
- JPRN-UMIN000029071
- Lead Sponsor
- Tanta university Obstetrics and Gynecology department
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Male factor all other causes of infertility untreated hypothyriodism hyperprolactinemia renal or hepatic impairment malabsorption syndrome
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical pregnancy rate
- Secondary Outcome Measures
Name Time Method weight reduction